Diabetes is not an independent risk factor for hepatocellular carcinoma

Diabetes/Metabolism Research and Reviews

Volumn 29, Issue 7, 2013, Pages 515-524

  Tseng, Chin Hsiao ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Detection bias; Diabetes; Hepatocellular carcinoma; Incidence; Taiwan

Indexed keywords

ACARBOSE; ALCOHOL; ALPHA FETOPROTEIN; HEPATITIS B SURFACE ANTIGEN; INSULIN; METFORMIN; PIOGLITAZONE; ROSIGLITAZONE; SULFONYLUREA; VIRUS ANTIBODY;

ALCOHOL LIVER CIRRHOSIS; ALCOHOL LIVER DISEASE; ALCOHOLISM; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CEREBROVASCULAR ACCIDENT; CHRONIC LIVER DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC PATIENT; DISEASE ASSOCIATION; DISEASE DURATION; DYSLIPIDEMIA; ECHOGRAPHY; FEMALE; HEPATITIS C VIRUS; HIGH RISK PATIENT; HUMAN; INSULIN TREATMENT; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; NATIONAL HEALTH INSURANCE; PATIENT SELECTION; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; TAIWAN;

DETECTION BIAS; DIABETES; HEPATOCELLULAR CARCINOMA; INCIDENCE; TAIWAN;

ADULT; CARCINOMA, HEPATOCELLULAR; DIABETES COMPLICATIONS; DIABETES MELLITUS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LIVER NEOPLASMS; MALE; RISK FACTORS; TAIWAN;

EID: 84884942109     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.2422     Document Type: Article

References (19)

1. Bosch FX, Ribes J, Díaz M, Cléries R. Primary liver cancer: worldwide incidence and trends. Gastroenterology 2004; 127(5 Suppl 1): S5-S16.
2. Chen DS. Hepatocellular carcinoma in Taiwan. Hepatol Res 2007; 37(Suppl 2): S101-S105.
3. Yang JD, Harmsen WS, Slettedahl SW, et al. Factors that affect risk for hepatocellular carcinoma and effects of surveillance. Clin Gastroenterol Hepatol 2011; 9: 617-6623.
4. El-Serag HB, Hampel H, Javadi F. The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. Clin Gastroenterol Hepatol 2006; 4: 369-380.
5. Blonski W, Kotlyar DS, Forde KA. Non-viral causes of hepatocellular carcinoma. World J Gastroenterol 2010; 16: 3603-3615.
6. Rossi M, Lipworth L, Maso LD, et al. Dietary glycemic load and hepatocellular carcinoma with or without chronic hepatitis infection. Ann Oncol 2009; 20: 1736-1740.
7. Donadon V, Balbi M, Ghersetti M, et al. Antidiabetic therapy and increased risk of hepatocellular carcinoma in chronic liver disease. World J Gastroenterol 2009; 15: 2506-2511.
8. Wang CS, Yao WJ, Chang TT, Wang ST, Chou P. The impact of type 2 diabetes on the development of hepatocellular carcinoma in different viral hepatitis statuses. Cancer Epidemiol Biomarkers Prev 2009; 18: 2054-2060.
9. Takahashi H, Mizuta T, Eguchi Y, et al. Post-challenge hyperglycemia is a significant risk factor for the development of hepatocellular carcinoma in patients with chronic hepatitis C. J Gastroenterol 2011; 46: 790-798.
10. Lai MS, Hsieh MS, Chiu YH, Chen TH. Type 2 diabetes and hepatocellular carcinoma: a cohort study in high prevalence area of hepatitis virus infection. Hepatology 2006; 43: 1295-1302.
11. Chen CL, Yang HI, Yang WS, et al. Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan. Gastroenterology 2008; 135: 111-121.
12. Tung HD, Wang JH, Tseng PL, et al. Neither diabetes mellitus nor overweight is a risk factor for hepatocellular carcinoma in a dual HBV and HCV endemic area: community cross-sectional and case-control studies. Am J Gastroenterol 2010; 105: 624-631.
13. Hassan MM, Curley SA, Li D, et al. Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma. Cancer 2010; 116: 1938-1946.
14. Kawaguchi T, Taniguchi E, Morita Y, et al. Association of exogenous insulin or sulphonylurea treatment with an increased incidence of hepatoma in patients with hepatitis C virus infection. Liver Int 2010; 30: 479-486.
15. Tseng CH, Chong CK, Sheu JJ, Wu TH, Tseng CP. Prevalence and risk factors for stroke in type 2 diabetic patients in Taiwan: a cross-sectional survey of a national sample by telephone interview. Diabet Med 2005; 22: 477-482.
16. Tseng CH. Prevalence of lower-extremity amputation among patients with diabetes mellitus: is height a factor? CMAJ 2006; 174: 319-323.
17. Tseng CH. Waist-to-height ratio and coronary artery disease in Taiwanese type 2 diabetic patients. Obesity 2008; 16: 2754-2759.
18. Tseng CH. Differential dyslipidemia associated with albuminuria in type 2 diabetic patients in Taiwan. Clin Biochem 2009; 42: 1019-1024.
19. Tseng CH, Tseng CP, Chong CK, et al. Increasing incidence of diagnosed type 2 diabetes in Taiwan: analysis of data from a national cohort. Diabetologia 2006; 49: 1755-1760.